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Oxidative stress contributes to the pathophysiology of expo-
sure  to  heavy  metals/metalloid.  Beneficial  renal  effects  of 
some  medications,  such  as  chelation  therapy  depend  at  least 
partially on the ability to alleviate oxidative stress. The admin-
istration of various natural or synthetic antioxidants has been 
shown  to  be  of  benefit  in  the  prevention  and  attenuation  of 
metal induced biochemical alterations. These include vitamins, 
N-acetylcysteine,  α-lipoic  acid,  melatonin,  dietary  flavonoids 
and  many  others.  Human  studies  are  limited  in  this  regard. 
Under certain conditions, surprisingly, the antioxidant supple-
ments may exhibit pro-oxidant properties and even worsen metal 
induced toxic damage. To date, the evidence is insufficient to 
recommend antioxidant supplements in subject with exposure 
to  metals.  Prospective,  controlled  clinical  trials  on  safety  and 
effectiveness of different therapeutic antioxidant strategies either 
individually or in combination with chelating agent are indis-
pensable.  The  present  review  focuses  on  structural,  chemical 
and biological aspects of antioxidants particularly related to their 
chelating properties.
Introduction
Oxidation  is  a  chemical  reaction  involving  transfer  of  an 
electron from electron rich to electron deficient entity. The elec-
tron deficient molecule is termed an oxidizer or oxidizing agent. 
Heavy metals due to the presence of vacant d-orbital behave as 
potent oxidizing agents. Metals and metal compounds are natural 
constituents  of  all  ecosystems,  moving  between  biological  and   
non-biological system.1 Numerous studies have reported toxic and 
carcinogenic effects induced when humans and animals are exposed 
to certain metals especially arsenic,2 lead,3 cadmium,4 chromium5 
and  mercury.6  A  growing  amount  of  results  provide  evidence 
that  toxic  and  carcinogenic  metals  are  capable  of  interacting 
with nuclear proteins and deoxyribonucleic acid (DNA) causing 
oxidative  deterioration  of  biological  macromolecules.  Detailed 
studies in the past two decades have shown that metals like iron, 
cadmium, chromium, mercury, arsenic and lead possess the ability 
to produce reactive free radical species, which start chain reaction 
resulting in oxidation of lipid termed as lipid peroxidation, protein   
oxidation and oxidation of nucleic acid like DNA and ribonucleic 
acid (RNA).7 Deleterious free radical-mediated oxidations occur   
in aerobic organism as a result of normal oxygen metabolism.
An antioxidant is a substance capable of preventing or slowing 
the oxidation of other molecules. Generally, an antioxidant can 
protect against metal toxicity by trapping free radicals thus termi-
nating the chain reaction, by chelating metal ion and preventing 
the reaction with reactive oxygen species or by chelating metal 
and maintaining it in a redox state leading to its incompetency to 
reduce molecular oxygen. Substances which protect biomolecules 
from free radical-mediated damage both in vivo and in vitro fall 
under this category. Reactive oxygen species (ROS) and Reactive 
Nitrogen  Species  (RNS):  (1)  are  generated  during  irradiation 
by UV light, by X-rays and by gamma rays; (2) are products of 
metal-catalyzed reactions; (3) are present as pollutants in the atmo-
sphere; (4) are produced by neutrophils and macrophages during 
inflammation; (5) are by-products of mitochondria-catalyzed elec-
tron transport reactions and other mechanisms.8 ROS at higher 
concentration  are  important  mediators  of  damage  to  cell  cell 
structures, including lipids and membranes, proteins and nucleic 
acids (termed oxidative stress).9 The harmful effects of ROS are 
balanced by the antioxidant action of non-enzymatic antioxidants 
in addition to antioxidant enzymes.10
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This paper examines a discussion of the various protec-
tive pathways that may be provided by the antioxidant 
network against the deleterious action of free radicals.
Chemistry and Biochemistry of Free Radicals
Reactions of free radicals. Free radicals can be defined 
as  molecules  or  molecular  fragments  containing  one 
or  more  unpaired  electrons.11  Although  this  definition 
does not specify exactly, where the unpaired electron is 
present, still it is preferred because it allows us to classify 
most of the transition metal ions as free radicals and thus 
better understand the close interrelation between 
oxygen and reactive metal ions. Due to presence 
of this unpaired electron, these radicals confer a 
considerable degree of reactivity.
Figure 1 shows the generation of some of the 
reactive oxygen species. The hydroperoxyl radical 
formed above dissociates to give superoxide anion 
radical at physiological pH 7.4. Superoxide anion 
can  further  interact  with  other  molecules  to 
generate other ROS either directly or prevalently 
through enzyme- or metal-catalyzed processes (O2
•-). Superoxide 
ion is rapidly detoxified initially to hydrogen peroxide because of 
its dismutation reaction to form hydrogen peroxide and oxygen12 
and finally to water by Cu, Zn-SOD and/or Mn-SOD.
Significant amounts of hydrogen peroxide are formed in the 
mitochondria and this is enriched with antioxidants such as super-
oxide dismutase (SOD) and glutathione peroxidase (GPx) which 
minimizes the oxidative stress.13
Fe  (II)  can  participate  in  the  Fenton  reaction,  generating   
highly  reactive  hydroxyl  radical.  Thus  under  stress  conditions 
O2
•- facilitates OH• production from H2O2 by making Fe (II) 
available for the Fenton reaction. On the other hand the superoxide   
radical participates in the Haber-Weiss reaction which combines 
a Fenton reaction and the reduction of Fe (III) by superoxide, 
yielding Fe (II) and oxygen.
Metal Induced Oxidative Stress
Numerous  studies  have  focused  on  metal-induced  toxicity 
and carcinogenicity, emphasizing their role in the generation of 
reactive oxygen and nitrogen species in biological systems, and 
the significance of this therein. Metal-mediated formation of free 
radicals may cause various modifications to DNA bases as well as 
can enhance lipid peroxidation (Fig. 2).
Oxidative stress, a condition describing the production of oxygen 
radicals beyond a threshold for proper antioxidant   neutralization, 
has been implicated as a pathologic condition in several cellular 
disorders. Besides ROS, metal exposure can also affect the genera-
tion  of  RNS.  Nitric  oxide  (NO)  is  a  messenger  molecule  that 
plays  an  important  role  in  neurotransmission,  vasodilation  and 
immune response.14 NO also possesses toxic effects such as pro-
oxidant effects, genotoxicity and mutagenicity. Production of NO 
is catalyzed mainly by NO synthases, which consist of neuronal, 
endothelial and inducible forms.15
A number of metals have been long known in literature for 
their toxicity and carcinogenicity. Increased amounts of iron in the 
body poses enhanced risk of a variety of diseases including vascular 
disease, cancer and certain neurological conditions.16,17 Copper at 
high concentration is known to cause metastasis of cancer cells.18 
Cobalt(II) complexes are known to produce oxygen radicals which 
causes heart toxicity.19,20
Arsenic is one of the most toxic elements and produces a variety 
of  ROS  including  superoxide  (O2
•-),  singlet  oxygen  (1O2),  the 
peroxyl radical (ROO•), nitric oxide (NO•), hydrogen peroxide 
(H2O2), dimethylarsinic peroxyl radicals [(CH3)2AsOO•] and also 
the dimethylarsinic radical [(CH3)2As•].21-24 As(III) enhances the 
production of heme oxygenase, an indicator of oxidative stress in 
a variety of human and mammalian cell types25 and generates free 
radicals in livers of mice.26 The production of ROS by various 
arsenic metabolites was confirmed by animal experiments.27
Different mechanisms have been accounted for the toxicity of 
arsenic. Arsenic (III) compounds bind to sulfhydryl (-SH) groups 
and can inhibit various enzymes, including glutathione reductase 
while Arsenic (V) inhibits PDH28 activity thus causing impaired 
glucose metabolism.28,29
Studies have shown that lead causes oxidative stress by inducing 
the generation of reactive oxygen species (ROS) and weakening the 
antioxidant defence system of cells.30-32 Depletion of cells’ major 
sulfhydryl reserves e.g., δ-aminolevulinic acid dehydratase (ALAD) 
seems to be an important indirect mechanism for   oxidative stress 
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Figure 1. Redox reaction showing generation of various Reactive Oxygen Species 
(ROS).
Figure 2. Effects of ROS on DNA damage leading to its role in carcinogenesis.Antioxidants and metal toxicity
These enzymes are important for maintaining critical balance in 
the glutathione redox state. Malondialdehyde (MDA) levels were 
strongly correlated with lead concentration in the tissues of lead 
exposed rats.38 The concentration of thiobarbituric acid reactive 
substance  (TBARS),  which  is  a  reflection  of  endogenous  lipid 
oxidation level, gets increased on lead exposure. The interaction 
of lead with oxyhaemoglobin (oxyHb) has been suggested as an 
important source of superoxide radical formation in RBCs.
Also  studies  have  demonstrated  the  reactions  of  hydroxyl 
radicals which leads to abstraction of a hydrogen atom from the 
protein polypeptide backbone to form a carbon-centered radical, 
which  under  aerobic  conditions  reacts  readily  with  dioxygen 
to  form  peroxyl  radical.47  Metal-catalyzed  damage  to  proteins 
involves  oxidative  scission,  loss  of  histidine  residues,  bityrosine 
crosslink,  the  introduction  of  carbonyl  groups,  and  the  forma-
tion of protein-centered alkyl, R•, alkoxyl, RO• and alkylperoxyl, 
ROO•, radicals.48
Nomenclature and Classification of Antioxidants
Table 1 lists categories in which various antioxidants have been 
characterized based on their structure, occurrence and mode of 
action, solubility and kinetics.
Kinetically antioxidants can be classifieds into six categories as 
below:
(1)  Antioxidants  that  break  chains  by  reacting  with  peroxyl 
radicals having weak O-H or N-H bonds: phenol, napthol, hydro-
quinone, aromatic amines and aminophenols.
(2)  Antioxidants  that  break  chains  by  reacting  with  alkyl   
radicals: quinones, nitrones, iminoquinones.
(3)  Hydro  peroxide  decomposing  antioxidants:  sulphide,   
phosphide, thiophosphate.
(4) Metal deactivating antioxidants: diamines, hydroxyl acids 
and bifunctional compounds.
(5) Cyclic chain termination by antioxidants: aromatic amines, 
nitroxyl radical, variable valence metal compounds.
(6) Synergism of action of several antioxidants: phenol sulphide 
in which phenolic group reacts with peroxyl radical and sulphide 
group with hydro peroxide.
Antioxidants  as  chelating  agents  and  their  mechanism  of 
action.  Non-enzymatic  antioxidants49  as  well  as  antioxidant 
enzymes50 (Fig. 3) are known to counteract the effect of ROS and 
RNS. These antioxidants are known to diffuse free radicals leading 
to limited risk of oxidative stress. At cellular and molecular level 
they inactivate ROS and under specific low concentration inhibit 
or delay oxidative processes by interrupting the radical chain reac-
tion. Antioxidants also chelate the metal ions responsible for the 
generation of ROS as they have the potentials to work in both 
aqueous and/or membrane domains.
Chelation is the formation of a metal ion complex in which 
the metal ion is associated with a charged or uncharged electron 
donor  referred  to  as  ligand. The  ligand  may  be  monodenate, 
bidenate  or  multidenate,  that  is,  it  may  attach  or  co-ordinate 
using one or two or more donor atoms. Bidenate ligands form 
ring  structures  that  include  the  metal  ion  and  the  two-ligand 
atoms attached to the metal.51 Their efficacy depends not solely 
on their affinity for the metal of interest but also on their affinity 
that is induced by redox-inactive metals.33,34 Further, zinc which 
usually serves as a cofactor of many enzymes could be replaced 
by  lead,  thereby  making  the  enzyme  inactive.  The  increased 
lipid  peroxidation  and  inhibition  of  enzymes  responsible  to 
prevent such oxidative damage have demonstrated lead induced 
oxidative injury.35 Lead induced disruption of the pro-oxidant/
antioxidant balance could induce injury via oxidative damage to 
critical biomolecules. A significant decrease in the activity of tissue 
superoxide dismutase (SOD), a free radical scavenger and metal-
loenzymes  (zinc/copper)  on  lead  exposure  has  been  reported.36 
Catalase is an efficient decomposer of H2O2 and known to be 
susceptible to lead toxicity.31 Lead induced decrease in brain GPx 
activity may arise as a consequence of impaired functional groups 
such as glutathione (GSH) and NADPH or selenium mediated 
detoxification of toxic metals.37 Antioxidant enzyme glutathione 
S-transferase (GST) is known to provide protection against oxida-
tive  stress  and  the  inhibition  of  this  enzyme  on  lead  exposure 
might be due to the depletion in the status of tissue thiol moiety. 
Table 1    Alphabetical classification of antioxidants, 
their categories with few examples
Alphabetical  Categories of  Examples 
name  antioxidants
Antioxidant C  Carotenoids  β-carotene, Lycopene, Lutein
Antioxidant E  Enzymes  SOD, Catalase, GPx
Antioxidant G  Glutathione  Glutathione
Antioxidant H  Hormones  Melatonin, Oestrogen
Antioxidant L  Lipid associated  Ubiquinol-10, N-acetyl 
  chemicals  cysteine, lipoic acid
Antioxidant M  Minerals  Zinc, Selenium, Copper
Antioxidant P  Phenolics  Quercetin, Catechin
Antioxidant S  Saponines, Steroids  Cortisone, Estradiol, Estriol
Antioxidant V  Vitamins  α-tocopherol, Ascorbic acid
Figure 3. Enzymatic and non enzymatic classification of antioxidants with 
few.
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Non-enzymatic antioxidants. Vitamin C. Vitamin C (ascorbic 
acid) is a very important, and powerful, antioxidant that works 
in  aqueous  environments  of  the  body.  Vitamin  C  cooperates   
with Vitamin E to regenerate α-tocopherol55 from α-tocopherol 
radicals in membranes and lipoproteins.
Ascorbic acid, behaves as a vinylogous carboxylic acid, wherein 
the double bond (“vinyl”) transmits electron pairs between the 
hydroxyl and the carbonyl. Ascorbate acts as an antioxidant by 
being  available  for  energetically  favorable  oxidation.  Reactive 
oxygen  species  oxidize  (take  electrons  from)  ascorbate  first  to 
monodehydroascorbate and then dehydroascorbate. The reactive 
oxygen species are reduced to water, while the oxidized forms of 
ascorbate are relatively stable and unreactive, and do not cause 
cellular damage.
A schematic diagram (Fig. 4) below shows the various forms of 
ascorbic acid (Vitamin C) and its reaction with radicals (R•).56,57
Vitamin  C  scavenges  the  aqueous  reactive  oxygen  species   
(ROS) by very rapid electron transfer that inhibits lipid peroxida-
tion.58,59  Animal  studies  have  suggested  an  antagonistic  effect   
of ascorbic acid on lead absorption with its excellent chelating 
ability  towards  lead  which  is  in  good  comparison  to  standard 
chelator ethylenediamine tetra acetic acid (EDTA).60,61
Metal  chelation  studies  have  shown  that  chelation  of  Zn(II)   
and Mn(II) ions takes place via two—OH groups while, Cd(II) 
ion binds via the O-3 atom only while the Hg(II) ion interaction 
leads to the oxidation of the ascorbic acid in aqueous solution.62 
Vitamin C in plasma increases dose-dependently resistance to-lipid 
peroxidation, even in the presence of redox-active iron or copper 
and H2O2.63
for  endogenous  metals.  An  ideal  chelator  should  have  high   
solubility  in  water,  resistance  to  biotransformation,  ability  to 
reach site of metal storage, ability to retain chelating ability at 
the pH of body fluid and property of forming metal complexes   
that are less toxic than the free metal ion.
An ideal heavy metal chelator should be able to enter the cell 
easily,  chelate  the  heavy  metal  from  its  complex  with  metallo-
thionein or other proteins, and increase the excretion of the metal 
without its redistribution to other organs or tissues.52 Chelation 
therapy compromises with various side effects especially loss of 
essential elements. Chelating agents shows their binding affinity 
almost  for  all  positively  charged  ions. Thus  there  is  a  need  of   
safe and effective treatment against heavy metal toxicity. If any 
antioxidant satisfy above mentioned criteria of chelating agent it 
could serves as a chelating agent with less side effects.
Enzymatic antioxidants. One of the most effective intracellular 
enzymatic  antioxidants  is  superoxide  dismutase  (SOD)  which   
catalyzes  the  dismutation  of  O2
•-  to  O2  with  remarkably  high   
reaction  rates  by  successive  oxidation  and  reduction  of  the   
transition metal ion and to the less-reactive species H2O2.53
Catalase is an enzyme present in the cells of plants, animals and 
aerobic bacteria.54 Catalase is located in a cell organelle called the 
peroxisome. The enzyme very efficiently promotes the conversion 
of hydrogen peroxide to water and molecular oxygen.
Glutathione metabolism is one of the most essential of anti- 
oxidative  defence  mechanisms.  GPx  enzymes  in  presence  of   
tripeptide glutathione (GSH) add two electrons to reduce perox-
ides.54  GPx  decomposes  peroxides  to  water  (or  alcohol)  while 
simultaneously  oxidizing  GSH.  The  antioxidant  properties  of   
these  enzymes  allow  them  to  eliminate  peroxides  as  potential 
substrates for the Fenton reaction.
Figure 4. Conversion of ascorbic acid into different reduced forms at various pH indicating possible binding sites and free electrons responsible for their 
antioxidant and chelating property.Antioxidants and metal toxicity
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in reducing liver and kidney arsenic burden supports the view that 
vitamin C acts as detoxifying agent by forming a poorly ionized 
but soluble complex.32 Thus Vitamin C supplementation perspec-
tive,  though  observed  in  animal  model,  will  have  sustainable 
curative value among the already afflicted populations, neutral-
izing impact on freshly emerging metal poisoning scenario and   
possible  proactive  protection  to  those  potentially  susceptible  to 
heavy metal exposure.
Vitamin E. Vitamin E exists in eight different isomeric forms 
of two substructures tocopherol and tocotrienol (Fig. 5).69 Both 
structures are similar except the tocotrienol structure has double 
bonds on the isoprenoid units.
α-tocopherol is the most active form of vitamin E in humans 
and is a powerful biological antioxidant which is considered to be 
the major membrane bound antioxidant employed by the cell.70 
Its main antioxidant function is protection against lipid perox- 
idation.  During  the  antioxidant  reaction,  α-tocopherol  is   
converted  to  a  α-tocopherol  radical  by  the  donation  of  labile 
hydrogen  to  a  lipid  or  lipid  peroxyl  radical. The  α-tocopherol 
radical can thus be reduced to the original α-tocopherol form by 
Other studies indicate the ability of ascorbic acid to regulate 
factors that may influence gene expression, apoptosis and other 
cellular functions.64
However, studies in humans have shown some mixed results. 
In  a  study  with  78  male  workers,  38  received  vitamin  C  and   
38 were given placebo no effect of absorption or excretion of lead 
was found.65 An inverse relationship between serum vitamin C 
and blood lead levels was found in a cross-sectional study which 
analyzed 4,213 young and 15,365 adult Americans with mean 
blood  lead  level  of  2.5–3.5  mg/dl.66 Yet  another  study  among   
85  volunteers  drinking  lead-containing  drinking  water  showed 
small reductions in lead retention.67
A  consistent  protective  effect  of  Vitamin  C  has  also  been   
found in lung and colorectal cancer.68
In a recent published study, our group reported the remarkable 
effects of combined treatment of vitamin C and succimers like 
meso 2,3-dimercaptosuccinic acid (DMSA) or its monoisoamyl 
derivative (MiADMSA) on inhibited blood ALAD activity and 
in particular its beneficial effect in reducing the arsenic induced 
oxidative stress. Co-administration of vitamin C and MiADMSA 
Figure 5. Chemical structure of α-tocopherol and α-tocotrienol indicating isoprenoid units.Antioxidants and metal toxicity
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Oxidized glutathione GSSG is accumulated inside the cells and 
the ratio of GSH/GSSG is a good measure of oxidative stress of 
an organisms.87 Too high a concentration of oxidized glutathione 
GSSG may damage many enzymes oxidatively. GSSG can react 
with  protein  sulfhydryl  groups  to  produce  protein-glutathione 
mixed disulphide:
α-Lipoic acid. α-Lipoic Acid (1,2-dithione-3-pentanoic acid) 
is a sulfur-containing antioxidant with metal-chelating and anti-
glycation capabilities. Unlike many anti-oxidants, which are active 
only in lipid or aqueous phase, lipoic acid is active in both lipid 
and aqueous phases.88 Due to an asymmetric carbon having four 
different attached groups; lipoic acid exists as a pair of R- and S-. 
Naturally occurring lipoic acid is the R-form, but synthetic lipoic 
acid (known as alpha lipoic acid) is a racemic mixture of R-form 
and S-form in which R-enantiomer is more biologically active than 
the S-enantiomer.89
Lipoic  acid  is  readily  digested,  absorbed  and  transported 
to  tissues.  A  chronic/carcinogenic  study  in  rats  reported  that   
racemic lipoic acid was found to be non-carcinogenic and did not 
show any evidences of target organ toxicity. The No Observed 
Adverse Effect Level (NOAEL) was considered to be 60 mg/kg 
bw/day.90
LA is readily absorbed from diet and is rapidly converted to 
Dihydrolipoic  acid  (DHLA)  by  NADH  or  NADPH  in  most 
tissues (Fig. 6). Studies have demonstrated superior anti-oxidant 
activity of DHLA as compared to LA. Since DHLA can neutralize 
free radicals it is known to regenerate Vitamin C which is even 
better than GSH89 and Vitamin E from their oxidized forms.91,92
DHLA  possess  metal  chelating  properties  which  help  the 
body to get rid of accumulated ingested toxins.93 It has been 
shown  previously  that  oxidants  may  lead  to  cell  death  via 
lysosomal  rupture  and  that  this  latter  event  may  involve 
intralysosomal  iron  which  catalyzes  Fenton-type  chemistry 
and  resultant  peroxidative  damage  to  lysosomal  membranes.   
LA  stabilize  lysosomes  against  oxidative  stress,  probably  by 
chelating  intralysosomal  iron  and,  consequently,  preventing 
intralysosomal Fenton reactions.
Packer  et  al.92,94  proposed  a  hypothesis  of  LA  inducing 
cystine/cysteine uptake which examined the role of LA in stim- 
ulating GSH biosynthesis. In rats subjected to reperfusion injury 
following cerebral ischemia, LA restores brain GSH content and 
dramatically reduces the mortality rate from 78% to 26%.95
ascorbic  acid.71 Vitamin  E  perform  a 
unique  function  by  interrupting  free 
radical chain reactions via capturing the 
free radical. The free hydroxyl group on 
the aromatic ring is responsible for the 
antioxidant  properties.  The  hydrogen 
from this group is donated to the free 
radical,  resulting  in  a  relatively  stable 
free radical form of the vitamin.
The  antioxidant  function  of  this 
micronutrient  enhances  immunity  by 
maintaining the functional and struc-
tural  integrity  of  important  immune 
cells.72  Vitamin  E  has  the  ability  to  prevent  cell  injury  by   
maintaining the sulfhydryl groups of membrane proteins and by 
quenching free radicals.73
Vitamin  E  has  been  reported  to  protect  against  arsenic 
toxicity.74-76  Protective  value  of  vitamin  E  in  arsenic  induced 
toxicity  could  be  attributed  mainly  to  its  antioxidant  property 
or its location in the cell membrane and its ability to stabilize 
membrane  by  interacting  with  fatty  acid  chain.77 We  reported 
increased antioxidant enzymes activities, and GSH concentration 
and decreased lipid per oxidation in animals co-administered with 
arsenic and vitamin E. Vitamin E may preserve cell membrane 
function including ion transport and membrane fluidity. It may 
also  prevent  the  release  of  Fe2+  and  Mg2+  from  their  binding 
proteins, potentially decreasing the rate of lipid per oxidation.78
Our  group  has  also  reported  beneficial  effects  of  vitamins 
supplementation during lead intoxication. Intramuscular adminis-
tration of vitamin E prevented inhibition of blood ALAD activity, 
elevation of urinary ALA excretion and was effective in reducing 
the lead induced altered biogenic amines levels in brain during 
the  concomitant  exposure  lead.79  Vitamin  E  supplementation 
during concomitant lead exposure also prevented lead deposition 
in liver and blood. Some of the protective effects of vitamin E also 
emerge directly from its antioxidant property and some through its 
influence on the drug metabolising enzyme system.80,81 We also 
reported that administration of vitamin E when given in combi-
nation  with  meso  2,3-dimercaptosuccinic  acid  (DMSA)  or  its 
monoisoamyl derivative (MiADMSA) produced profound recov-
eries in sub-chronically lead exposed rat.82 Although, the group 
suggest that vitamin C was better in providing clinical recoveries 
and Vitamin E was equally efficient in decreasing the lead burden 
from the tissues.
Studies have also shown that vitamin E reduces the incidence of 
coloretal cancer by initiating the apoptosis of cancer cells.83,84
Glutathione.  The  major  thiol  antioxidant  is  the  tripeptide, 
glutathione.  Glutathione  (GSH)  is  a  multifunctional  intracel-
lular  non-enzymatic  antioxidant  which  is  considered  to  be  the 
major thiol-disulphide redox buffer of the cell.85 Generally, the   
antioxidant capacity of thiol compounds is due to the sulphur 
atom which can easily accommodate the loss of a single electron.86 
The reaction of glutathione with the radical R• as well as combina-
tion with another thiol radical is shown in:
Figure 6. Oxidized and reduced form of lipoic acid showing presence of thiol groups as the possible 
metal chelating sites.Antioxidants and metal toxicity
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Thus the possible mechanisms for the protecting effects of LA 
against oxidative stress may be as follows: (a) LA can be reduced to 
dihydrolipoic acid by NADH, (b) DHLA is a strong antioxidant 
to scavenge excess oxidants, and recycle other antioxidants such 
as  vitamin  E,  C  and  glutathione,  (c)  DHLA  chelate  metals  to   
prevent free radical generation92,94,108,109 thus to diminish oxidant 
attacks  on  bio-macromolecules,  (d)  LA  is  the  key  co-factor  of 
pyruvate  dehydrogenase  and  alphaketoglutaric  dehydrogenase 
the enzymes sensitive to oxidative stress, (e) supplementation of 
sufficient LA helps to fully stimulate activities of enzymes, thereby 
promoting and ameliorating oxidative phosphorylation and mito-
chondrial respiration110 and (f) LA can promote the antioxidant 
defense  by  inducing  phase  two  enzymes,  such  as  glutathione 
synthetase to elevate antioxidant GSH.111,112
Lipoic acid (LA) regenerates GSH from GSSG and dihydroli-
poic acid (DHLA) recycles ascorbic acid (AA) and dihydroascorbic 
acid (DHAA). DHLA restores vitamin E (VE) also.
LA satisfies two criteria to be a chelating agent i.e., absorption 
into the intracellular environment and complexing metals previ-
ously bound to other sulfhydryl proteins. Both LA and DHLA 
can chelate heavy metals, but the R-form is more effective for 
chelation.109 LA is most effective in chelating Cu2+, Zn2+ and 
Pb2+,  but  cannot  chelate  Fe3+  while  DHLA  forms  complexes 
with Cu2+, Zn2+, Pb2+, Hg2+ and Fe3+ that are poorly soluble in 
water. Although DHLA chelates Fe3+, it can also reduce Fe3+ to 
Fe2+ which shows its pro-oxidant efficacy. In so far as most iron 
is tightly bound to ferritin protein, DHLA may have the capacity 
to remove bound iron from ferritin. DHLA chelation of iron and 
copper in the brain may reduce free-radical damage contributing 
to  Alzheimer’s  disease.113  Small  amounts  of  cadmium  (Cd2+) 
can cause significant lipid peroxidation in the brain, which can 
be prevented by lipoic acid.114 Metal chelation by lipoic acid is 
presented in Figure 7.
LA  in  unbound  form  is  chemically  able  to  trap  circulating 
heavy metals, thus preventing cellular damage caused by metal 
toxicity.114 LA is lipophilic and is able to penetrate cell membranes 
and reach high intracellular concentrations within 30 seconds of 
its administration. Oral doses of 10 mg/kg LA in rats reaches peak 
levels  in  the  cerebral  cortex,  spinal  cord  and  peripheral  nerves 
within 30 minutes of administration and studies of chronic daily 
dosing conclude that LA reaches all areas of the central nervous 
system (CNS) and peripheral nervous system thus decreasing lipid 
peroxidation  in  brain  and  sciatic  nerve  tissue.94  Shila  et  al.115 
reported reduced arsenic concentration in brain tissue of animals 
supplemented with arsenic and LA. Lipoic acid might also have 
the capability to interfere with the absorption of arsenic. Beneficial 
role of LA against lead116 and GaAs100 toxicity in terms of lead 
and arsenic chelation form blood and soft tissues have also been 
reported.
N-acetylcysteine.  N-acetyl-L-cysteine  (NAC),  is  a  thiol-
containing  anti-oxidant  that  has  been  used  to  mitigate  various 
conditions  of  oxidative  stress.  It  reduces  liver  injury  caused  by 
paracetamol over dosage in human116 and attenuates liver injury 
and prevents liver and plasma GSH depletion in mice.117 Its anti-
oxidant action is believed to originate from its ability to stimulate 
GSH  synthesis,  therefore  maintaining  intracellular  GSH  levels   
LA has been reported to be effective in reducing the amount of 
OH• generated by Fenton type reactions and also a scavenger of 
peroxide and O2
•-.96 Sadi et al.97 proposed the increase in level of 
SOD and catalase after incubating with LA in diabetic rats towards 
normal value. Antioxidant effects of LA is based on their interac-
tions with peroxyl radicals, which are essential for the initiation 
of lipid peroxidation; and ascorbyl radicals of vitamin C. DHLA,   
can recycle ascorbyl radicals and reduce dehydroascorbate gener-
ated in the course of ascorbate oxidation by radicals. Therefore, 
DHLA may act as a strong chain-breaking antioxidant and may 
enhance the antioxidant potency of other antioxidants like vitamin 
C in both the aqueous and in hydrophobic membrane phase.98   
In addition to its antioxidant properties, LA can be neuroprotec-
tive in vivo through suppression of glial reactivity.99 Since chronic 
reactive gliosis exacerbates diabetic neuropathy, the administration 
of LA can prevent neuropathy by reducing both oxidative stress 
and glial hyperactivity.99 Bhatt et al.100 have reported antioxidant 
potential (redox potential of LA/DHLA -320 mV) and greater 
efficacy of LA over captopril and quercetin against gallium arsenide 
(GaAs) induced oxidative stress in rats.
LA has long been known as an essential cofactor for mitochon-
drial bio-energetic enzymes. Various in vitro and in vivo studies 
suggest that LA also acts as a powerful micronutrient with diverse 
pharmacologic  and  antioxidant  properties.  Pharmacologically, 
LA improves glycemic control, polyneuropathies associated with 
diabetes mellitus, and effectively mitigates toxicities associated with 
heavy metal poisoning. As an antioxidant, LA directly terminates 
free radicals, chelates transition metal ions (e.g., iron and copper), 
increases cytosolic glutathione and vitamin C levels and prevents 
toxicities associated with their loss. These diverse actions suggest 
that  LA  acts  by  multiple mechanisms  both  physiologically and 
pharmacologically.101 The relatively good scavenging activity of 
lipoic acid is due to the strained conformation of the 5-membered 
ring in the intramolecular disulfide.102
Exogenous administration of LA has been found to have thera-
peutic potential in neurodegenerative disorders also. LA can also 
cross the blood-brain barrier103 and is taken up by all areas of the 
central  and  peripheral  nervous  system.  Lipid  peroxides  (LPO) 
are the presumptive markers of free radical-associated oxidative 
stress.104-106 Free radical attack on poly unsaturated fatty acids 
(PUFA) in the biological system is thought to produce a sequence 
of reactions, which lead to the formation of both conjugated dienes 
and lipid hydroperoxides.107
Figure 7. Reduced form of lipoic acid showing metal chelation at thiol 
groups (M = Cu2+, Zn2+, Cd2+, Pb2+, Hg2+ and Fe3+).Antioxidants and metal toxicity
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NAC pretreated animal effectively detoxifies or removes arsenic via   
GSH  dependent  pathway.  It  is  probably  due  to  an  enhanced 
ability  to  maintain  GSH  homeostasis  during  exposure  to  toxic 
electrophiles generated by arsenic as well as its rapid elimination/
excretion from the body.
Besides  arsenic  NAC  shows  chelating  property  against  lead 
also.126 One of the first report by Pande et al.127 suggested that 
NAC could be used both as preventive as well as therapeutic agent 
along with MiADMSA/DMSA in the prevention or treatment of 
lead intoxication in rats. They reported that co-administration of 
NAC with DMSA reversed the altered ALAD and TBARS levels, 
increased the GSH level and decreased the lead level from blood 
and soft tissues. They proposed that NAC administration have a 
beneficial role, which is independent of chelation. However, no 
change in blood glutathione levels in lead exposed rats, as well 
as in NAC administered rats, provides a more complex theory 
that  either  all  of  the  free  sulfhydryl  group  may  be  utilized  in 
complexing  circulatory  lead  or  perhaps  the  lead  concentration 
in  blood  following  exposure  could  not  reach  alarmingly  high 
to  influence  blood  GSH.128,129  A  recent  report  suggested  that 
co-administration of NAC along with DMSA in sub-chronically 
lead exposed rats reduced oxidative stress significantly by lowering 
the TBARS and GSSG level along with decreased lead burden 
from soft tissues especially brain.130
Beside the antioxidant potential NAC, has also shown to have 
various  other  important  functions,  like  the  antimutagenic  and 
and  scavenging  ROS.118,119  NAC,  is  rapidly  deacetylated  to 
cysteine  and  thus  may  increase  GSH  levels  by  providing  the 
substrate for the rate limiting step in GSH synthesis.120 Structure 
of NAC along with possible chelating sites is presented in Figure 
8.
NAC  is  known  to  have  metal-chelating  properties  and  has 
been used in several clinical conditions.121 Thiol groups present 
in NAC act to reduce free radical and provide chelating site for 
metals. Thus, NAC has a strong ability to restore the impaired pro-
oxidant/antioxidant balance in metal poisoning. NAC can cross 
the cell membrane therefore provide intracellular effects. Martin 
et al.122 reported a better response of acute arsenic symptoms to 
intravenous NAC than intramuscular 2,3-dimercapto-1-propanol. 
We recently provided evidence of a novel therapeutic combina-
tion to achieve greater effectiveness in chelation treatment against 
chronic arsenic intoxication in rats.123 Combined administration 
of NAC and Succimer post arsenic exposure led to a significant 
turnover in the variables indicative of oxidative stress and removal 
of toxic metal (arsenic) from the soft organs.123 This combination 
provided  a  more  pronounced  reduction  in  the  arsenic  induced 
oxidative stress in liver and brain beside a rapid depletion of soft 
tissue arsenic burden compared to treatment with DMSA or NAC 
alone. The major hypothesis behind this new protocol was that, 
(1) NAC beside a strong antioxidant is a thiol compound and 
thus, will provide an additional site for metal chelation; and (2) 
NAC, because of its ability to restore the impaired pro-oxidant: 
antioxidant balance, will accelerate clinical or biochemical recov-
eries. Modi et al.124 proposed protective efficacy of Zn and NAC 
co-administration against arsenic induced oxidative stress. Santra 
et al.125 reported that in arsenic-induced liver cell injury in mice 
is associated with induction of oxidative stress, the perturbations 
in the mitochondrial redox state and arsenic-induced apoptosis of 
hepatocytes and all these changes were reduced in intensity and/or 
modified by pretreatment with NAC. They showed that on treat-
ment with NAC could replete cellular stores of the tripeptide GSH 
and  are  an  effective  intervention  against  oxidative  stress  devel-
oped due to arsenic exposure. They also proposed that observed 
hepatoprotection  provided  by  NAC  could  because  the  liver  of 
Figure 8. Structure of N-acetyl cysteine (NAC) depicting (1) two chelating sites (thiol and hydroxyl) and (2) deacetylation responsible for its antioxidant 
potential due to the generation of glutathione.
Figure 9. Structure of taurine showing sulfonate group as an electrophilic 
and amide group as a nucleophilic center responsible for it chelating and 
antioxidant properties, respectively.Antioxidants and metal toxicity
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this in part might explain the significant elimination of lead from 
the brain tissues. Flora et al.142 have reported that taurine when 
administered along with MiADMSA could significantly reduce the   
arsenic concentration in blood, liver and kidneys. This suggests 
that the antioxidant capacity of taurine becomes most effective 
when it is administered along with the thiol chelators or taurine 
might be facilitating the entry of chelator to the intracellular sites 
thereby reducing arsenic concentration.
Carotenoids. Carotenoids (Car) are pigments that are found 
in  plants  and  microorganisms.  Various  studies  have  indicated 
that carotenoids may prevent or inhibit certain types of cancer,   
arthrosclerosis,  age-related  muscular  degeneration  and  other 
diseases.
The  antioxidant  activity  of  carotenoids  arises  primarily  as 
a  consequence  of  the  ability  of  the  conjugated  double-bonded 
structure  to  delocalize  unpaired  electrons.154  This  is  primarily 
responsible  for  the  excellent  ability  of  α-carotene  to  physically 
quench singlet oxygen without degradation, and for the chemical 
reactivity  of  α-carotene  with  free  radicals  such  as  the  peroxyl 
(ROO•), hydroxyl (•OH) and superoxide radicals (O2
•-). At suffi-
ciently high concentrations, carotenoids can protect lipids from 
peroxidative damage.155 Carotenoids have antiproliferative effect 
on various cancer cell lines; lycopene has been shown to inhibit   
cell  cycle  progression  in  breast,  lung  and  prostate  cell  lines. 
β-Carotene  has  been  shown  to  inhibit  the  expression  of  anti-
apoptotic protein Bcl-2 in cancer cells, reducing thus growth of 
cancer cells.156
Flavonoids.  Polyphenolic  compounds  constitute  one  of  the 
most  commonly  occurring  and  ubiquitous  groups  of  plant 
metabolites and represent an integral part of human.157-159 Their 
common structural feature is the diphenylpropane moiety, which 
consists of two aromatic rings linked through three carbon atoms 
that together usually form an oxygenated heterocycle. Phenolic 
compounds acting as antioxidants may function as terminators of 
free radical chains and as chelators of redox-active metal ions that 
are capable of catalyzing lipid peroxidation.159
One of the most actively studied properties of flavonoids is their 
protection against oxidative stress.158,160 For example, flavonoids 
are  ideal  scavengers  of  peroxyl  radicals  due  to  their  favorable 
reduction potentials relative to alkyl peroxyl radicals and thus, 
in principle, they are effective inhibitors of lipid peroxidation.160 
Of  particular  importance  is  the  hydrogen  (electron)  donating 
ability of a flavonoid molecule which acts to scavenge a reactive 
radical species, and is primarily associated with the presence of 
a B-ring catechol group (dihydroxylated B-ring). One important 
structural feature which is partly responsible for the antioxidant 
properties of flavonoids involves the presence of 2,3 unsaturation 
in conjugation with a 4-oxo group in the C-ring. In addition, the 
presence of functional groups involving both hydroxyl groups of   
ring-B  and  the  5-hydroxy  group  of  ring-A  are  all  important 
contributors in the ability of flavonoids to chelate redox-active 
metals and thus prevent catalytic breakdown of hydrogen peroxide 
(Fenton chemistry).
Quercetin.  Quercetin  is  one  of  the  most  frequently  studied 
bioflavonoid. Flavonoids are polyphenolic compounds possessing 
15 carbon atoms, two benzene rings joined by a linear three carbon 
anticarcinogenic, in vitro and in vivo. NAC has been demonstrated 
to inhibit the in vivo DNA adduct formation after administration 
of aminothiorene or benzopyrene exposure. NAC is also known 
to  protect  certain  enzymes  involved  in  DNA  replication  and 
repair.131,132
Taurine. Taurine (2-aminoethanesulfonic acid) is a nonessen-
tial sulfur-containing amino acid that functions with glycine and 
gamma-amino butyric acid as a neuro inhibitory transmitter.133 
The zwitterionic nature of taurine gives it high water solubility and 
low lipophilicity. Consequently compared with carboxylic amino 
acids, diffusion through lipo-philic membranes is slow for taurine. 
It acts as a metabolic transmitter and additionally has a detoxi-
fying  effect  and  strengthens  cardiac  contractility.  It  crosses  the 
blood brain barrier134,135 and has been implicated in a wide array 
of physiological phenomena including long term potentiation in 
the  striatum/hippocampus136  membrane  stablization137  calcium 
homeostasis138 and protection against glutamate excitotoxicity.139 
It  also  acts  as  an  antioxidant  and  protects  against  toxicity  of 
various heavy metals including arsenic, lead and cadmium.140-142 
Zahorodnyi and Nebesna143 established that the sulfonate group 
of taurine is a electrophilic center and amide group is a nucleo-
philic center (Fig. 9). The biggest value of electrostatic potential 
is located around sulfonate group. This big value of energy of low 
occupied molecular orbital of taurine gives grounds to consider 
this substance as a reducing reagent and explains its antioxidant 
properties.
Low levels of taurine have been associated with retinal degen-
eration,  growth  retardation  and  cardiomyopathy.144,145 Taurine 
has also been used clinically in the treatment of cardiovascular 
diseases, hypercholesterolemia, seizure disorders, ocular disorders, 
diabetes,  Alzheimer’s  disease,  hepatic  disorders,  cystic  fibrosis 
and alcoholism.146,147 Taurine can act as a direct antioxidant by 
scavenging reactive oxygen species or as an indirect antioxidant 
by preventing changes in membrane permeability due to oxidant 
injury.148-150 As a direct antioxidant, taurine is able to quench and 
detoxify some reactive intermediates such as hypochlorous acid 
generated  by  myeloperoxidase149  nitric  oxide148  and  H2O2.151 
On  the  other  hand,  as  an  indirect  antioxidant,  taurine  protect 
cells via intercalating into the membrane and stabilizing it.152 The 
membrane protective effects of taurine are suggested to be related 
to an action on permeability to ions and water.150
In  the  studies  conducted  by  Gurer  and  Ercal80  taurine  was 
shown to have beneficial effects in lead induced oxidative stress 
in Chinese Hamster Ovary (CHO) cells and rats. An antioxidant 
mechanisms rather than a chelating activity, seems to underlie this 
observed effects of taurine against lead-induced oxidative stress. 
We recently described the dose dependent effect of taurine, either 
alone or in combination with meso 2,3-dimercaptosuccinic acid 
(DMSA) in the treatment of sub-chronic lead intoxication in male 
rats.153 The results suggested beneficial role of taurine when admin-
istered along-with DMSA in providing effective reversal of number 
of lead sensitive biochemical variables in general, and parameters of 
oxidative stress in particular, compared to their individual effects. 
We  noted  significant  effect  of  taurine  when  co-administered 
with DMSA, in depleting blood and brain lead. It is known that 
highest concentration of taurine is in brain and heart. Perhaps Antioxidants and metal toxicity
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The propensity of a flavonoid to inhibit free-radical mediated 
events is governed by its chemical structure. Multiple hydroxyl 
groups  confer  upon  the  molecule  substantial  antioxidant,  and 
chelating  ability.  A  double  bond  and  carbonyl  function  in  the 
heterocycle or polymerization of the nuclear structure increases 
activity by affording a more stable flavonoid radical through conju-
gation and electron delocalization.173 Quercetin has the ability to 
form semiquinone and quinine type compounds by undergoing 
one or two electron oxidation respectively. In this form it is able to 
chelate metal ions and form five member chelating ring.174
Its  anti-radical  property  is  directed  to  scavenge  OH.  and 
the  superoxide  anion,  highly  reactive  species  implicated  in  the 
initiation of lipid peroxidation. On the other hand, quercetin as 
a phenolic compound, may act as a metal-chelating agent, and in 
fact, it belongs to a special class of bidentate O,O-coordinating 
ligands which is capable of undergoing both one or two electron 
oxidations, forming semiquinone and quinone type compounds 
respectively.175-177  There  are  many  reports  in  the  literature  of 
quercetin-metal complexes but most of these are solution studies 
in which no compounds were isolated. Bravo and Anacona,178 
have reported coordination site at quercetin and its bonding prop-
erties on the basis of spectroscopic analysis. They proposed that 
carbonyl oxygen atom does not participate in coordination to the 
metal ions and coordination proceeds through the ortho-phenolic 
groups located on the quercetin B ring (Fig. 10). Their ability to 
form  complexes  with  some  p-,  d-  and  f-electron  metals  makes 
them  interesting  analytical  reagents.  Quercetin  possesses  three 
possible chelating sites in competition: the 3-hydroxychromone, 
the  5-hydroxychromone  and  the  3',4'-dihydroxyl  groups  and 
is most widely used for detection of metals bound to flavonoid 
ligands  owing  to  their  highly  sensitive  molecular  fluorescence   
properties. Analytical procedures have been developed for Al, Cr, 
W, Zr, Ti, Fe, Mo, Zr, Hf, Ge, Ru, Pd, Os, Pt and Au.179
Quercetin  contains  numerous  double  bonds  and  hydroxyl 
groups that can donate electrons through resonance to stabilize the 
free radicals.180 The radical scavenging properties associated with 
the structure of quercetin defend against oxidative stress and in 
doing so, reduce heart disease, prevent cancer, and slow the aging 
atom chain (structure A). The chemical structure of flavonoids   
are based on a C15 skeleton with a chromane ring bearing a second 
aromatic ring B in position 2, 3 or 4 (structure B).
    A      B
Various subgroups of flavonoids are classified according to the 
substitution patterns of ring C. Both the oxidation state of the 
heterocyclic ring and the position of ring B are important in the 
classification.
The flavonol quercetin (3',3,4',5,7-pentahydroxyflavone) is one 
of the most abundant dietary flavonoids.161 It is found in many 
fruits and vegetables, as well as olive oil, red wine and tea.162,163 
A recent report indicates that blood plasma concentrations may 
reach  in  excess  of  20  μM  quercetin  and  quercetin  metabolites 
in  response  to  quercetin-rich  diets.164  Quercetin  was  found  to 
scavenge  free  radicals  and  reduce  the  oxidability  and  cytotoxic 
effects of low density lipoproteins.165,166 High consumption of 
flavonoid rich food has therefore also been linked to a reduced 
incidence of cancers at various sites.167 Quercetin have multiple 
biological,  pharmacological  and  medicinal  properties  including 
anti-inflammatory,  anti-allergic,  antiviral,  antithrombotic,  anti-
mutagenic,  antineoplastic  and  cytoprotective  effects.168  Various 
epidemiological  and  dietary  studies  suggest  that  quercetin  may 
play a useful role in preventing neurodegeneration, especially age-
related  cognitive,  motor  and  mood  decline  and  protect  against 
oxidative stress as well as cerebral ischemic injuries.169 Quercetin 
induces growth inhibition and cell death in a variety of cancer cells 
including glioma cells.170,171 Quercetin has been reported to have 
both protective and detrimental effects.172 The precise molecular 
mechanism of quercetin action is poorly understood. Quercetin 
might exert the protective effect against the cell death associated 
with generation of ROS.
Figure 10. Structure of quercetin showing coordination through the ortho-phenolic groups located on the B ring.Antioxidants and metal toxicity
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ring o-dihydroxyl groups, the 4-oxo group in conjugation with 
the 2,3-alkene, and the 3- and 5-hydroxyl groups.181 The func-
tional groups can donate electrons to the rings, which increase the 
number of resonance forms available in addition to those created 
by the benzene structure.187
Many flavonoids are bound to sugars in their natural state, the 
O-glycoside form, where glycosylation can occur at any hydroxyl 
group to yield a sugar. The most common quercetin glycosides 
have a sugar group at the 3-position, such as quercetin-3-O-β-
glucoside shown in Figure 11.
Glycosylated structures are most common in nature, not the 
parent  compound.188  Most  studies  assessing  the  antioxidant 
properties of quercetin utilize the parent form; however, analysis 
of  plasma  after  quercetin  consumption  indicates  that  quercetin 
metabolites,  like  glucuronide  (quercetin-3-O-β-D-glucuronide), 
are the primary compounds circulating in the blood.189
Quercetin can also protect against the more obvious 
environmental  causes  of  free  radicals,  such  as  smoking. 
Cigarette tar is a source of free radicals, which has been 
found  to  damage  erythrocyte  membranes.  Begum  and 
Terao,190  found  that  the  quercetin  and  its  conjugate 
metabolites (quercetin-3-O-β-glucuronide and quercetin-
3-O-β-glucoside)  could  protect  erythrocytes  from  the 
membranous  damage  that  is  caused  by  smoking.  The 
control used in the study was flavone, which has the basic 
structure  of  quercetin  but  no  hydroxyl  groups,  and  it 
had no effect on the erythrocytes. This indicated that the 
hydroxyl groups are important to the antioxidant proper-
ties of quercetin.
Quercetin  is  also  reported  to  prevent  apoptosis  in 
several  cells  such  as  fibroblasts,  cardiomyoblasts,  and 
epithelial cells.191,192 Quercetin was found to attenuate 
oxidative damage induced by arsenic by restoring GSH 
contents and ROS levels and reducing TBARS levels.193 
Quercetin  has  also  been  reported  to  increase  metallothionein 
expression and prevent cadmium-induced Nephrotoxicity.194  In 
spite  of  these  positive  effects  of  quercetin,  there  have  been  a 
number of conflicting report about quercetin like it acts as a pro-
oxidant or has some moderate toxicity195 however, it is widely 
accepted that the beneficial effects of quercetin are due mainly to 
its antioxidant properties and also due to regulation of signaling 
pathway. Quercetin administration was also found to be associ-
ated with reduced condition of oxidative stress induced by GaAs 
exposure.100 Mishra et al.193 have also reported that the combined 
treatment with quercetin and MiADMSA was not only able to 
chelate arsenic from the cell but also ameliorate oxidant levels, i.e., 
abatement of toxic effects of arsenic.
Garlic. Garlic (Allium sativum L., family Liliaceae), called Lasan 
in India, is a medicinal plant which has been used for thousands 
of years in Indian Ayurvedic medicine. It is also used with spices 
to give a special flavor and fragnance to the food. Garlic contains a 
number of organosulfur compounds which are widely believed to 
be the active agents.194 The major medicinal compound obtained 
from garlic is Allicin, a powerful anti-biotic and anti-fungal agent. 
Precursor of Allicin is alliin which on decomposition with pyruvic 
acid and ammonia in the presence of garlic constitutional enzyme 
processes in cells responsible for degenerative diseases.181 Quercetin 
interfere by reacting with the radicals formed in the process of   
lipid  peroxidation.181-183  Quercetin  does  not  only  stop  the   
propagation of lipid peroxidation, but also increases glutathione 
(GSH) levels.184 GSH can convert hydrogen peroxide to oxygen 
and water, preventing the formation of free radicals.184 Oxidative 
stress can cause cell death by means of prolonged elevations of 
intracellular Ca2+ concentrations.185 Quercetin can protect cells 
suffering  oxidative  stress  and  thus  prevent  Ca2+-dependent  cell 
death.185
The  oxidation  of  low-density  lipoproteins  (LDL)  can  result 
in the formation of atherosclerotic plaques, leading to cardiovas-
cular  disease.181  Quercetin  has  displayed  the  ability  to  prevent 
the oxidation of LDL by scavenging free radicals and chelating 
transition metal ions. Graf and co-workers found a 21% reduction 
in cardiovascular disease mortality when the intake of quercetin 
was greater than 4 mg/day.186 Quercetin when reacts with a free 
radical, it donates a proton and becomes a radical itself, but the 
resulting unpaired electron is delocalized by resonance, making 
the quercetin radical too low in energy to be reactive.187 Three 
structural groups aid in quercetin’s ability to maintain its stability 
and act as an antioxidant when reacting with free radicals: the B 
Figure  11.  Structure  of  Quercetin-3-O-β-glucoside,  a  naturally  occuring 
predominat form of Glycosylated Quercetin.
Figure 12. Structures of major constituents of garlic depicting thiol and amino moi-
eties (the possible sites for metal chelation) along with the ketonic, sulphonic and 
hydroxyl groups (responsible for their antioxidant activity).Antioxidants and metal toxicity
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of cancer cells of murine and human origin. Allicin induced the 
formation of apoptotic bodies, nuclear condensation and a typical 
DNA ladder in cancer cells along with activation of caspases-3, -8 
and -9 and cleavage of poly(ADP-ribose) polymerase.213 Horie et 
al.214 demonstrated that AGE prevents the formation of thiobarbi-
turic acid-reactive substances during lipid peroxidation of rat liver 
microsomes. Among a variety of organosulfur compounds, SAC and 
S-allylmercaptocysteine (SAMC), major organosulfur compounds 
found in AGE, showed radical scavenging activity indicating that 
these compounds may play an important role in the antioxidative 
activity of AGE. These results suggest that the antioxidant effect of 
AGE may be due to its modulation of the glutathione redox cycle 
and SOD activity in vascular endothelial cells.
Sanapati et al.215 reported the prophylactic efficacy of garlic 
against lead and found that aqueous extract of garlic have ability 
to reduce lead burden from soft tissues. Choudhury et al.216,217 
reported co-administration of garlic extract is able to reduce the 
clasotogenic  effects  of  sodium  arsenite.  Apart  from  the  benefi-
cial role of garlic extract in arsenic induced oxidative stress they 
suggested the critical role of p53 and heat shock proteins. Recently 
Flora et al.218 reported that concomitant administration of garlic 
extract reduced tissue arsenic burden as well as increased urinary 
arsenic excretion. This phenomenon could be attributed to the 
thiosulphur components present in the garlic extract which may 
act as Lewis acids and interact with Lewis base (arsenic) to form 
stable  components.219,220  Chowdhury  et  al.221  suggested  that 
diverse  components  of  aqueous  garlic  extracts  like  allicin  also 
participate in possible chelation of arsenic. These authors suggested 
that  sulphur  bearing  components  of  aqueous  garlic  extract  are 
lipophilic and hence can permeate freely through phospholipids 
membrane.221,222
Conclusion
This  review  provides  an  insight  on  the  beneficial  effects  of 
different antioxidants in preventing arsenic or lead body burden 
and oxidative stress. The main structural features in antioxidants 
are the presence of -SH/-OH group either in the parent molecule 
or in their reduced form. It suggest that if an antioxidant molecule 
is able to provide free electron either in the form of a negative 
charge or in the form of a lone pair of electrons it may provide a 
chelating site for toxic metal. Besides, providing beneficial effects 
in eliminating heavy metal body burden and thereby reversing the 
altered biochemical variables these antioxidants could be useful in 
enhancing endogenous antioxidant levels. These antioxidants may 
also be supplemented during chelation therapy with a thiol chelator 
to get optimum therapeutic effects with fewer side effects.223,224
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alliinase gives Allicin. Whenever any part of the garlic is damaged, 
Allicin is formed which has the characteristic odor of garlic.
The  major  sulfur-containing  compounds  in  intact  garlic  are 
γ-glutamyl-S-allyl-L-cysteines  and  S-allyl-L-cysteine  sulfoxides 
(alliin). Both are abundant as sulfur compounds, and alliin is the 
primary  odorless,  sulfur-containing  amino  acid,  a  precursor  of 
Allicin, methiin, (+)-S-(trans-1-propenyl)-L-cysteine sulfoxide, and 
cycloalliin.195 These sulfoxides, except cyloalliin, are converted into 
thiosulfinates through enzyme reactions when raw garlic is cut or 
crushed. Besides this, a number of other antibiotic principles have 
also been isolated, namely, methyl-allyl thiosulfinates, 1-propenyl 
allyl thiosulfinate, L-glutamyl-S-alkyl-L-cysteine, S-allyl mercap-
tocysteine,  diallyl  disulfide,  -trisufide,  allyl  methyl  trisulfide, 
-disulfide, diallyl tetra sulfide, allyl methyl tetra sulfide, Dimethyl 
trisulfide,  Diallyl  sulfide,  2-vinyl-4-H-1,3-dithiin,  3-vinyl-4-H-
1,2-dithiin, E-ajoene, Z-ajoene, Allyl mercaptan.196 Structures of 
some important constituents of garlic are illustrated in Figure 12.
Amagase197  described  formation  of  thiosulfinates  such  as 
Allicin  through  the  enzymatic  reaction  of  sulfur-substituted 
cysteine sulfoxides, via sulfur-substituted sulfenic acids as a highly 
reactive intermediate.
According to the recent pharmacological findings, garlic is a 
preventive rather than therapeutic. The pharmacological effects of 
garlic have mostly been attributed to its hypoglycemic198 hypo-
lipidimic199  anticoagulant,  antihypertensive200  antihepatotoxic, 
anticancer, immune system modulatory, antiatherosclerotic, anti-
microbial, antidote (for heavy metal poisoning) and antioxidant 
properties.196,197 In addition to this, the bulb of garlic is used as 
an antirheumatic and stimulant beside its use in conditions like 
paralysis, forgetfulness, tumor colicky pain and chronic fever.201 
Recent studies have demonstrated that garlic exerts its therapeutic 
effect by increasing nitric oxide (NO) production.202,203
It is also found to have free radical scavenging action and inhibits 
oxidative modification of low-density lipoproteins.204 The intrinsic 
antioxidant activity of garlic, aged garlic extracts (AGE) and some 
garlic constituents have been widely documented in vivo205 and in 
vitro.206 LDL oxidation has been recognized as playing an impor-
tant role in the initiation and progression of atherosclerosis. Popov 
and Lewin,207 observed the antioxidant effect of the aqueous extract 
from a dehydrated garlic-powder preparation by using photochemi-
luminescence on the Cu(2+)-initiated oxidation of LDL. AGE and 
S-allylcysteine (SAC) inhibited both lactate-dehydrogenase release 
and lipid peroxidation induced by H2O2. It is also reported that garlic 
extract shows its antioxidant activity by increases SOD, glutathione 
peroxidase  and  catalase  activity  in  vascular  cell  and  culture.208-
211  Furthermore,  Geng  and  Lau,208  showed  that  AGE  increases   
intracellular glutathione levels, glutathione disulfide reductase, and 
SOD activity in bovine pulmonary artery endothelial cells, whereas 
the level of glutathione disulfide decreased. Geng et al.212 determined 
the effects of SAC on NFκB cultivation in human T lymphocytes 
(Jurkat cells) induced by tumor necrosis factor alpha and H2O2. 
SAC consistently inhibited NFκB activation induced by both tumor 
necrosis  factor  alpha  and  H2O2  in  nuclear  extracts. The  results 
suggest that SAC might act through antioxidant mechanisms to 
block NFκB activation in Jurkat cells. Allicin also inhibit the growth Antioxidants and metal toxicity
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